Showing results (1331-1340 of 6,130) with videos related to

Sort By:
Pageof 613
International Journal of Antimicrobial Agents|November 13, 2022
Voriconazole therapeutic drug monitoring and hepatotoxicity in critically ill patients: A nationwide multi-centre retrospective studyTaotao Wang, Liyan Miao, Hua Shao, et al.
International Journal of Antimicrobial Agents|August 2, 2022
Catecholate siderophore receptor CirA impacts cefiderocol susceptibility in Klebsiella pneumoniaePeng Lan, Ye Lu, Yan Jiang, et al.
International Journal of Antimicrobial Agents|September 21, 2025
A pharmacometric model assessing the in vitro synergistic effect of a bacteriophage-polymyxin B combination in a clinical multidrug-resistant Klebsiella pneumoniae isolateAneeq Farooq, Sue C Nang, Heidi H Yu, et al.
International Journal of Antimicrobial Agents|August 15, 2025
Microbiome and Antibiotic Resistance Profile of Milk and Faeces from Cattle in an Organized Dairy Production SystemMonica Rose Amarlapudi, Chandrasekhar Balasubramaniam, Akash, et al.
International Journal of Antimicrobial Agents|September 10, 2025
LightCPPgen: An explainable machine learning pipeline for rational design of cell penetrating peptidesGabriele Maroni, Filip Stojceski, Lorenzo Pallante, et al.
International Journal of Antimicrobial Agents|September 8, 2025
The prospect of approved and commercially available phage therapeuticsHarald König
International Journal of Antimicrobial Agents|July 31, 2025
Changes of colistin pharmacokinetics in critically ill patients due to the extracorporeal membrane oxygenation: Results of the COL-ECMO2022 trialPavel Suk, Jitka Rychlíčková, Lenka Součková, et al.
International Journal of Antimicrobial Agents|August 15, 2021
In vitro evaluation of antimicrobial resistance selection in Neisseria gonorrhoeaeGeorge P Allen, Kristina M Deao, Stephanie A Hill, et al.
International Journal of Antimicrobial Agents|August 22, 2021
Antimicrobial effect of auranofin against Acanthamoeba sppAlvie Loufouma Mbouaka, David Leitsch, Martina Koehsler, et al.
International Journal of Antimicrobial Agents|June 14, 2020
Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitorsJun He, Lijun Hu, Xiaojun Huang, et al.
Pageof 613